A Look At Vaxcyte (PCVX) Valuation As Share Price Momentum Rebuilds [Yahoo! Finance]
Vaxcyte, Inc. (PCVX)
Company Research
Source: Yahoo! Finance
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Vaxcyte (PCVX) has been drawing attention after recent share price moves, with the stock closing at US$61.74 and showing mixed total returns over the past year and multi year periods. See our latest analysis for Vaxcyte. The recent 1 month share price return of 15.25% and 90 day return of 35.63% suggest momentum has been building, even though the 1 year total shareholder return of a 15.45% decline contrasts with the much stronger 3 and 5 year total shareholder returns of 45.13% and 159.85%. If you are tracking vaccine and biotech names like Vaxcyte, it can also be useful to widen the lens with a curated set of 27 healthcare AI stocks that our screener has surfaced. With shares at US$61.74, a value score of 3, no current revenue and a sizeable reported loss, the key question is whether Vaxcyte is still undervalued or if the recent rebound already reflects expect
Show less
Read more
Impact Snapshot
Event Time:
PCVX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PCVX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PCVX alerts
High impacting Vaxcyte, Inc. news events
Weekly update
A roundup of the hottest topics
PCVX
News
- Does Heavy 2025 Loss and Large Equity Raise for Vaxcyte's VAX-31 Shift the Bull Case (PCVX)? [Yahoo! Finance]Yahoo! Finance
- Love A Little Risk? Wall Street Sees Massive Upside in Vaxcyte Stock. [Yahoo! Finance]Yahoo! Finance
- Vaxcyte Advances VAX-31 Toward Phase 3 As Valuation Gap Persists [Yahoo! Finance]Yahoo! Finance
- Vaxcyte, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- Vaxcyte (PCVX) had its "buy" rating reaffirmed by BTIG Research.MarketBeat
PCVX
Earnings
- 2/24/26 - Miss
PCVX
Sec Filings
- 3/2/26 - Form 4
- 3/2/26 - Form 4
- 3/2/26 - Form 4
- PCVX's page on the SEC website